Ashton Thomas Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Ashton Thomas Private Wealth’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.34M	Sell	28,054 -4,230	-13%	-$727K	0.11%	191
2026 Q1	$5.45M	Sell	32,284 -3,483	-10%	-$596K	0.13%	172
2025 Q4	$6.04M	Buy	35,767 +4,054	+13%	+$658K	0.15%	152
2025 Q3	$4.58M	Sell	31,713 -31,978	-50%	-$4.36M	0.12%	195
2025 Q2	$8.06M	Buy	63,691 +56,369	+770%	+$6.92M	0.28%	83
2025 Q1	$936K	Sell	7,322 -16,180	-69%	-$2.19M	0.04%	398
2024 Q4	$3.11M	Buy	23,502 +18,211	+344%	+$2.56M	0.12%	203
2024 Q3	$770K	Hold	5,291	–	–	0.04%	363
2024 Q2	$726K	Hold	5,291	–	–	0.04%	353
2024 Q1	$726K	Buy	5,291 +1,784	+51%	+$244K	0.04%	353
2023 Q4	$476K	Buy	3,507 +108	+3%	+$13.2K	0.03%	435
2023 Q3	$416K	Buy	3,399 +1,314	+63%	+$167K	0.03%	425
2023 Q2	$265K	Buy	+2,085	New	+$271K	0.02%	505

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Ashton Thomas Private Wealth's IBB Position: Q2 2026 in Review

Ashton Thomas Private Wealth reduced its iShares Biotechnology ETF (IBB) stake by 13% in Q2 2026, selling an estimated $727K and leaving 28,054 shares worth $5.34M. The position accounts for 0.11% of the portfolio, ranked #191.

Ashton Thomas Private Wealth first reported a position in IBB in Q2 2023 and has held it in 13 quarters since. The position peaked at $8.06M in Q2 2025. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Ashton Thomas Private Wealth held 28,054 shares of iShares Biotechnology ETF worth $5.34M as of Q2 2026.
Ashton Thomas Private Wealth sold 4,230 iShares Biotechnology ETF shares in Q2 2026, an estimated $727K.
iShares Biotechnology ETF made up 0.11% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #191 holding.
Ashton Thomas Private Wealth first reported a position in iShares Biotechnology ETF in Q2 2023 and has held it in 13 quarters since.
Ashton Thomas Private Wealth's iShares Biotechnology ETF position peaked at $8.06M in Q2 2025.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.